Dequilla, Jesus M.
HRN: 18-20-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/21/2023
03/27/2023
IVT
600mg
Q8
Pneumonia, Unaerobic Coverage
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes